Maryland-based Novavax’s effort to vaccinate the world, from zero to not quite warp speed: ‘This takes time and expertise’

Novavax, the Gaithersburg-based vaccine development company, has been given more than $2 billion to develop a COVID vaccine and the means to produce it globally, but it's been hampered by a variety of issues.